Evrysdi
Evrysdi
Evrysdi
Human medicines European public assessment report (EPAR): Esmya, ulipristal, Date of authorisation: 22/02/2012, Revision: 16, Status: Withdrawn
Human medicines European public assessment report (EPAR): Raxone, idebenone, Date of authorisation: 08/09/2015, Revision: 11, Status: Authorised
PSUSA/00001158/202411
PRAC recommendations on signals adopted at the 7-10 July 2025 PRAC meeting
List of signals discussed at PRAC since September 2012
Human medicines European public assessment report (EPAR): Aucatzyl, obecabtagene autoleucel, Date of authorisation: 17/07/2025, Status: Authorised
European Medicines Agency’s data protection notice for the use of EMA Authentication Services and Microsoft Entra ID
Records of data processing activity for EMA Authentication Services and Microsoft Entra ID
CHMP PROM minutes for the meeting on 14 April 2025